“Thermosensitive In Situ Nasal Gel Incorporating Chitosan Nanoparticles of Zolmitriptan for Migraine Management: Formulation Strategies, Optimization, and Characterization— A Review”. International Journal of Pharmaceutical Drug Design 3, no. 1 (May 9, 2026): 196–204. Accessed May 11, 2026. https://ijpdd.org/index.php/files/article/view/375.